1985
DOI: 10.2214/ajr.145.5.1061
|View full text |Cite
|
Sign up to set email alerts
|

Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
46
0
1

Year Published

1989
1989
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(48 citation statements)
references
References 8 publications
0
46
0
1
Order By: Relevance
“…ERC with biliary balloon dilatation and/or stenting as well as biliary cytology brushing is frequently employed in the evaluation and management of DSs and may yield clinical benefit and valuable diagnostic information 9, 19, 20, 21, 22, 23, 24, 25, 26. Indeed, a study by Baluyut et al18 of 63 asymptomatic and symptomatic patients with PSC and a DS who underwent endoscopic therapy with balloon dilatation revealed improved 5‐year survival as estimated by the Mayo Risk Score; this study and others18, 27 suggest that endoscopic intervention for DSs may confer a sustained benefit and potentially alter the natural history of PSC.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…ERC with biliary balloon dilatation and/or stenting as well as biliary cytology brushing is frequently employed in the evaluation and management of DSs and may yield clinical benefit and valuable diagnostic information 9, 19, 20, 21, 22, 23, 24, 25, 26. Indeed, a study by Baluyut et al18 of 63 asymptomatic and symptomatic patients with PSC and a DS who underwent endoscopic therapy with balloon dilatation revealed improved 5‐year survival as estimated by the Mayo Risk Score; this study and others18, 27 suggest that endoscopic intervention for DSs may confer a sustained benefit and potentially alter the natural history of PSC.…”
Section: Discussionmentioning
confidence: 99%
“…Median transplant‐free survival from time of PSC diagnosis is variable, ranging from approximately 12‐21 years in most studies, with more recent estimates being toward the top end of this range 4, 5, 6, 7, 8. It has been reported that 40%‐58% of patients with PSC will develop focal high‐grade strictures, referred to as a “dominant stricture” (DS), during the course of disease 5, 9, 10, 11, 12. Patients with a DS may remain asymptomatic or may present with worsening serum liver tests, abdominal pain, and/or cholangitis 9.…”
mentioning
confidence: 99%
“…Such lesions may be amenable to nonoperative endoscopic or radiologic dilatation with or without a biliary drainage procedure such as sphincterotomy and stenting, which lead to improvement of clinical symptoms, liver biochemistries, and cholangiographic findings. 24,25 The choice of endoscopic or percutaneous approaches for biliary decompression should be dictated by the site and complexity of the stricture(s), and the availability of local expertise. However, neither endoscopic nor percutaneous dilatation with or without stenting have been shown to have a clear impact on survival, and many of these patients will eventually undergo liver transplantation.…”
Section: Management Of Stenosismentioning
confidence: 99%
“…DOMINANT BILIARY STRICTURES. Dominant strictures of the extrahepatic bile duct occur in 7-20% of patients with PSC (18,43). Several studies reported successful management with endoscopic balloon dilation or biliary stenting of the dominant strictures (44 -47).…”
Section: Management Of Chronic Cholestasis and Its Complicationsmentioning
confidence: 99%